{"pub_date": "2016-11-21T19:05:25Z", "subsection_name": "DealBook", "lead_paragraph": "The case appears to be a straightforward tale of avarice, but the Justice Department may have a difficult time proving the charges.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "HENNING", "firstname": "Peter", "role": "reported", "middlename": "J."}], "original": "By PETER J. HENNING"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "White Collar Watch", "main": "Kickback Case Questions Whether Valeant Was Victim or Participant", "kicker": "White Collar Watch"}, "source": "The New York Times", "blog": [], "word_count": "1216", "web_url": "http://www.nytimes.com/2016/11/21/business/dealbook/kickback-case-questions-whether-valeant-was-victim-or-participant.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The case appears to be a straightforward tale of avarice, but the Justice Department may have a difficult time proving the charges....", "_id": "5833458d7c459f6a5fccf39d", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Securities and Commodities Violations", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Philidor Rx Services LLC", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N"}, {"rank": "4", "name": "persons", "value": "Tanner, Gary", "is_major": "N"}, {"rank": "5", "name": "persons", "value": "Davenport, Andrew", "is_major": "N"}, {"rank": "6", "name": "organizations", "value": "Securities and Exchange Commission", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}